RONALD PAULS: Open Payments
NPI 1912182627 · SEMINOLE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 32 payments from 7 companies in 2025. Trend: 2023 $616 · 2024 $360 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $207 |
| Lilly USA, LLC | 7 | $115 |
| PFIZER INC. | 4 | $73 |
| Amgen Inc. | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Novo Nordisk Inc | 1 | $19 |
Products named: MOUNJARO, VRAYLAR, PREVNAR 20, UBRELVY, QULIPTA, OTEZLA, GEMTESA, REXULTI.
Industry payments across OK — which companies pay providers there.
